Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pregnenolone
Cat. No.:
OB0225LY-0477
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Pregnenolone is a steroid hormone precursor involved in a variety of biosynthetic processes.
Synonym:
3β-Hydroxy-5-pregnen-20-one; Arthenolone; 145-13-1; 3beta-Hydroxypregn-5-en-20-one; 5-Pregnen-3beta-ol-20-one; 3-Hydroxy-5-pregnen-20-one
CAS No.:
145-13-1
Compound CID:
8955
Formula:
C21H32O2
Formula Weight:
316.48
Specification
Relative Density:
1.09 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pregnenolone can be used in neuroprotection studies or play an important role in the study of endocrine regulation.
Library Information
Targets:
G protein-coupled receptors (GPCRs); Ion channels
Receptors:
Cannabinoid receptor; mAChR; TRP/TRPV channel
Pathways:
Metabolism; Autophagy; GPCR/G protein; Membrane transporter/Ion channel; Neuronal signaling
Plate Number:
AOCL-7
Plate Location:
b6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
3.33 mg/mL; 10.53 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
21 mg/mL; 66.4 mM
